Tikvah Therapeutics, an Atlanta-based company specializing in drug treatments for CNS disorders, has raised $10 million of bridge financing from undisclosed investors according to VentureWire (vw). www.tikvahtherapeutics.com
Tikvah Therapeutics, an Atlanta-based company specializing in drug treatments for CNS disorders, has raised $10 million of bridge financing from undisclosed investors according to VentureWire (vw). www.tikvahtherapeutics.com
Copyright PEI Media
Not for publication, email or dissemination